GRIP1 in Myeloid Cells in Neuroinflammation

GRIP1 is a glutamate receptor interacting protein 1 and myeloid cells consists of granulocytes and monocytes, before they have differentiated and are derived from hematopoietic stem cells. The interaction between GRIP1 and myeloid cells in inflammation is in the early stages. Here is the latest research on GRIP1 and myeloid cells in inflammation.

August 21, 2020
Open Access

Myeloid Pannexin-1 mediates acute leukocyte infiltration and leads to worse outcomes after brain trauma

Journal of Neuroinflammation
Joon Ho SeoJorge E Contreras
October 7, 2020
Open Access

Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis

International Journal of Molecular Sciences
Ettore DolcettiGeorgia Mandolesi
December 18, 2020
Open Access

Differential Roles of TREM2+ Microglia in Anterograde and Retrograde Axonal Injury Models

Frontiers in Cellular Neuroscience
Gemma ManichBernardo Castellano
October 9, 2020
Open Access

Neuroinflammation alters the phenotype of lymphangiogenic vessels near the cribriform plate.

BioRxiv : the Preprint Server for Biology
Martin HSUZ. Fabry
October 13, 2020
Open Access

Transcription cofactor GRIP1 differentially affects myeloid cell-driven neuroinflammation and response to IFN-β therapy

The Journal of Experimental Medicine
Sanda MimounaInez Rogatsky
December 3, 2020
Open Access

Potential caveats of putative microglia-specific markers for assessment of age-related cerebrovascular neuroinflammation

Journal of Neuroinflammation
Pedram HonarpishehLouise D McCullough
September 9, 2020
Open Access

Senescent Accelerated Prone 8 (SAMP8) Mice as A Model of Age Dependent Neuroinflammation

Andrés FernándezEva Cano
September 18, 2020
Open Access

CSF Biomarker Profiles in CNS Infection Associated with HSV and VZV Mimic Pattern in Alzheimer’s Disease.

Makiko ShinomotoTakahiko Tokuda
July 28, 2020
Open Access

A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy

Journal of Neuroinflammation
Xavier TaylorCristian A Lasagna-Reeves
November 18, 2020

Effects of (-)-epicatechin on neuroinflammation and hyperphosphorylation of tau in the hippocampus of aged mice

Food & Function
Viridiana Navarrete-YañezIsrael Ramirez-Sanchez
July 25, 2020
Open Access

Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice

Molecular Neurodegeneration
Nicholas F FitzRadosveta Koldamova
July 25, 2020
Open Access

Gasdermin-D-dependent IL-1α release from microglia promotes protective immunity during chronic Toxoplasma gondii infection

Nature Communications
Samantha J BatistaTajie H Harris
December 29, 2020
Open Access

The Joint-Brain Axis: Insights From Rheumatoid Arthritis on the Crosstalk Between Chronic Peripheral Inflammation and the Brain

Frontiers in Immunology
Patrick SüßJürgen Winkler
September 10, 2020
Open Access

Microglia Gone Awry: Linking Immunometabolism to Neurodegeneration

Frontiers in Cellular Neuroscience
Ruqayya AfridiKyoungho Suk
September 22, 2020
Open Access

Effects of long-term and brain-wide colonization of peripheral bone marrow-derived myeloid cells in the CNS

Journal of Neuroinflammation
Lindsay A HohsfieldKim N Green

Sign up to follow this feed and discover related papers.

Related Feeds

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

© 2021 Meta ULC. All rights reserved